Colgate-Palmolive (NYSE:CL) Stock Keeps "Outperform" Rating at BNP Paribas Exane

Key Points

• BNP Paribas Exane reaffirmed its “outperform” rating on Colgate-Palmolive and raised its price target from $97 to $108, implying approximately 12% upside from the prior close.
• Analyst sentiment remains positive overall, with 13 Buy ratings and seven Holds; the consensus rating is “Moderate Buy” with an average price target of $100.78.
• Colgate-Palmolive exceeded quarterly expectations, reporting $0.97 in earnings per share and $5.37 billion in revenue, with revenue up 4.6% year over year.

Colgate-Palmolive (NYSE:CL - Get Free Report)'s stock had its "outperform" rating reaffirmed by equities research analysts at BNP Paribas Exane in a report released on Monday, Benzinga reports. They presently have a $108.00 target price on the stock, up from their prior target price of $97.00. BNP Paribas Exane's price objective indicates a potential upside of 12.01% from the company's previous close.

A number of other analysts also recently commented on CL. Evercore boosted their price objective on Colgate-Palmolive from $100.00 to $101.00 and gave the stock an "outperform" rating in a research note on Thursday, October 8th. JPMorgan Chase & Co. lowered their price objective on shares of Colgate-Palmolive from $104.00 to $102.00 and set an "overweight" rating on the stock in a research report on Monday. Raymond James Financial boosted their price target on Colgate-Palmolive from $100.00 to $102.00 and gave the company an "outperform" rating in a research note on Monday, August 3rd. TD Cowen boosted their price target on Colgate-Palmolive from $90.00 to $97.00 and gave the stock a "hold" rating in a research report on Monday. Finally, Morgan Stanley raised their target price on shares of Colgate-Palmolive from $104.00 to $111.00 and gave the company an "overweight" rating in a research note on Monday. Thirteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company's stock. According to MarketBeat, Colgate-Palmolive currently has a consensus rating of "Moderate Buy" and an average target price of $100.78.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock traded up $1.13 during trading hours on Monday, reaching $96.42. The company's stock had a trading volume of 1,565,734 shares, compared to its average volume of 5,625,901. The company's 50 day simple moving average is $89.54 and its 200 day simple moving average is $89.65. The stock has a market cap of $76.86 billion, a P/E ratio of 37.77, a price-to-earnings-growth ratio of 4.59 and a beta of 0.31. The company has a debt-to-equity ratio of 13.82, a quick ratio of 0.30 and a current ratio of 0.46. Colgate-Palmolive has a one year low of $74.54 and a one year high of $99.33.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, October 30th. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.04. Colgate-Palmolive had a net margin of 9.65% and a return on equity of 607.88%. The firm had revenue of $5.37 billion for the quarter, compared to the consensus estimate of $5.34 billion. During the same period last year, the firm posted $0.91 EPS. Colgate-Palmolive's quarterly revenue was up 4.6% compared to the same quarter last year. As a group, analysts expect that Colgate-Palmolive will post 3.89 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director John T. Cahill sold 4,170 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $93.37, for a total transaction of $389,352.90. Following the completion of the sale, the director owned 28,373 shares in the company, valued at $2,649,187.01. The trade was a 12.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, COO Panagiotis Tsourapas sold 10,000 shares of the stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $92.05, for a total transaction of $920,500.00. Following the completion of the transaction, the chief operating officer owned 64,901 shares in the company, valued at $5,974,137.05. This represents a 13.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 175,191 shares of company stock worth $16,110,903 in the last quarter. Insiders own 0.43% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Virginia Estate & Retirement Planning Advisors Inc. raised its position in shares of Colgate-Palmolive by 1,409.1% during the third quarter. Virginia Estate & Retirement Planning Advisors Inc. now owns 332 shares of the company's stock worth $28,000 after purchasing an additional 310 shares during the period. Parvin Asset Management LLC acquired a new stake in Colgate-Palmolive during the second quarter worth approximately $32,000. Park Place Capital Corp grew its position in shares of Colgate-Palmolive by 55.5% in the second quarter. Park Place Capital Corp now owns 356 shares of the company's stock valued at $33,000 after purchasing an additional 127 shares during the last quarter. Gould Capital LLC boosted its holdings in Colgate-Palmolive by 38.7% in the 1st quarter. Gould Capital LLC now owns 412 shares of the company's stock valued at $35,000 after purchasing an additional 115 shares during the period. Finally, Montgomery Financial Services LLC acquired a new position in shares of Colgate-Palmolive during the 2nd quarter worth approximately $36,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Better-than-expected quarterly results: Colgate-Palmolive reported third-quarter earnings of $0.97 per share, above the $0.93 consensus estimate, while revenue rose 4.6% year over year to $5.37 billion, slightly exceeding expectations. Colgate-Palmolive Analysts Boost Their Forecasts After Upbeat Q3 Earnings
• Positive Sentiment: Improved outlook: Management narrowed its 2026 sales outlook while raising its margin and earnings-per-share guidance, signaling improved confidence in profitability and supporting the positive market reaction. Colgate-Palmolive sales rise 4.6% and it lifts margin and EPS outlook
• Positive Sentiment: Analyst target increases: RBC raised its price target from $104 to $105 and maintained an “outperform” rating. Wells Fargo also increased its target from $90 to $95, despite retaining an “equal weight” rating.
• Neutral Sentiment: Mixed analyst signals: JPMorgan lowered its target from $104 to $102 but kept an “overweight” rating, while Barclays maintained a “hold” rating. These actions suggest continued confidence in the business but limited near-term upside at the current valuation.
• Negative Sentiment: Lingering profit concerns: Commentary following the earnings report noted that questions remain about profit growth, which could restrain further gains if cost pressures or weaker-than-expected margins emerge. Colgate Palmolive Stock Climbs After Q3 Earnings Yet Profit Questions Linger

Colgate-Palmolive Company Profile

Colgate-Palmolive Company NYSE: CL is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill's Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill's Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.